Global Blood Stream Infection Testing Market to Reach $13.19 Billion by 2029, Growing at 12% CAGR

"What Is the Expected Size and Growth Rate of the Blood Stream Infection Testing Market?
The market size for blood stream infection testing has seen a fast-paced expansion in recent years. It is projected to increase from $7.59 billion in 2024 to $8.49 billion in 2025, marking a compound annual growth rate (CAGR) of 11.9%. The growth witnessed during the historic period is due to the increasing cases of hospital-acquired infections, a rise in antimicrobial resistance, a larger aging population, elevated healthcare spending, and the ongoing growth in chronic disease prevalence.

Expectations are high for a swift expansion in the blood stream infection testing market within the next few years. It is forecasted to swell to $13.19 billion in 2029, experiencing a compound annual growth rate (CAGR) of 11.7%. The surge during the forecast period may be credited to the escalating demand for immediate diagnostic tests, the increasing acceptance of molecular diagnostics, the growing emphasis on personalized medicine, governmental efforts towards infection management, and the rising occurrence of multi-drug-resistant pathogens. Key trends during this prediction period include the rising employment of AI in diagnostic devices, the merging of telemedicine with diagnostic services, the increasing demand for home-based testing kits, the creation of multiplex diagnostic platforms, and the advanced collaborations between diagnostic businesses and hospitals.

What Factors Are Fueling Growth in the Blood Stream Infection Testing Market?
The escalating occurrence of transmittable ailments is anticipated to spur the expansion of the blood stream infection testing market. These illnesses are triggered by harmful microbes such as bacteria, viruses, fungi, or parasites. There's a surge in the rates of infectious diseases due to several factors such as heightened global travel, urban development, climate alterations, antibiotic resistance, and inconsistencies in vaccination implementation. Bloodstream infection testing becomes critical in diagnosing and verifying the pathogens responsible for sepsis and other serious infections, thus providing targeted and potent treatment. For instance, the latest World Malaria report from the Switzerland-based United Nations agency, the World Health Organization, disclosed that there were 249 million malaria cases in 2022, an increase from 244 million in 2021. The projected number of malaria deaths were 608,000 in 2022, slightly down from 610,000 in 2021. Therefore, the escalating incidence of infectious diseases is propelling the growth of the blood stream infection testing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20514&type=smp

Which Leading Companies Are Shaping the Growth of the Blood Stream Infection Testing Market?
Major companies operating in the blood stream infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthcare Private Limited, Becton Dickinson and Company (BD), Grifols S.A., Hologic Inc., BIOMÉRIEUX SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., DiaSorin S.p.A., Seegene Inc., Cepheid, Meridian Bioscience Inc., Biocartis NV, T2 Biosystems Inc., Molzym GmbH & Co. KG, Curetis GmbH, Accelerate Diagnostics Inc., OpGen Inc.

Which Leading Companies Are Shaping the Growth of the Market?
Leading businesses in the bloodstream infection testing market are concentrating on the creation of novel products, like blood testing cartridges, to maintain their market dominance. Blood testing cartridges are single-use devices utilized in diagnostic tests for blood sample analysis. These cartridges come equipped with pre-inserted reagents and built-in sensors or microfluidic conduits, making it easier to identify specific biomarkers, pathogens or conditions from minimal blood samples. For instance, Immunexpress Pty Ltd., a molecular diagnostics company based in Australia, launched the SeptiCyte RAPID cartridges in August 2022. These cartridges rely on undiluted ethylenediaminetetraacetic acid (EDTA) blood as an approved sample type, which has shown a high correlation with other types of blood collection methods in a European multi-site study. This innovation enhances the precision and efficiency of sepsis diagnosis, paving the way for broader and faster clinical implementation. In turn, it can revolutionize patient care while reducing healthcare expenditures.

What Are the Key Segments of the Blood Stream Infection Testing Market?
The blood stream infection testing market covered in this report is segmented -

1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Sample Type: Whole Blood, Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR), Mass Spectroscopy, In Situ Hybridization, Other Technologies
4) By End-User: Hospitals And Diagnostic Centers, Laboratory Service Providers, Academic And Research Institutes, Other End-Users

Subsegments:
1) By Instruments: Blood Culture Systems, Automated Microbial Identification Systems, Molecular Diagnostic Instruments
2) By Reagents and Consumables: Blood Culture Media, Antimicrobial Susceptibility Testing Reagents, Nucleic Acid Extraction Kits
3) By Software and Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/blood-stream-infection-testing-global-market-report

Which Region Dominates the Blood Stream Infection Testing Market?
North America was the largest region in the blood stream infection testing market in 2024. The regions covered in the blood stream infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Blood Stream Infection Testing Global Market Report?

- Market Size Analysis: Analyze the blood stream infection testing Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the blood stream infection testing market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall blood stream infection testing market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the blood stream infection testing market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20514

"

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
•LinkedIn: https://in.linkedin.com/company/the-business-research-company
•Twitter: https://twitter.com/tbrc_info
•YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.